Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study on the Response of Inherited Erythromelalgia Patients With NaV1.7 Mutations to Carbamazepine: Clinical Imaging Study

NCT02214615 is registered in ClinicalTrials.gov with VA Connecticut Healthcare System as lead sponsor.

NCT NCT02214615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study on the Response of Inherited Erythromelalgia Patients With NaV1.7 Mutations to Carbamazepine: Clinical Imaging Study
Lead sponsor
VA Connecticut Healthcare System
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
July 31, 2016
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

erythromelalgia